Cost-effectiveness analysis of expectant vs active management for treatment of persistent pregnancies of unknown location.
Jessica R WalterKurt T BarnhartNathanael C KoelperNanette F SantoroHeping ZhangTracey R ThomasHao HuangHeidi S Harvienull nullPublished in: American journal of obstetrics and gynecology (2024)
The management of pregnancies of unknown location with a 2-dose methotrexate protocol may be cost-effective compared with expectant management and uterine evacuation. Although uterine evacuation was dominated, expectant management vs methotrexate results were sensitive to modest changes in treatment costs of both methotrexate and surgical management.